38 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Downtrend
Article Searches
Is Allergan (AGN) a Great Stock for Value Investors? http://www.zacks.com/stock/news/338321/is-allergan-agn-a-great-stock-for-value-investors?cid=CS-ZC-FT-338321 Nov 19, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Hedge funds are in a 'vicious downward cycle' as their favorite stocks badly trail market https://www.cnbc.com/2018/11/21/hedge-funds-are-in-a-vicious-downward-cycle-as-their-favorite-stocks-trail.html Nov 21, 2018 - A collection of hedge funds' favorite stock picks — including Facebook, Alibaba and Amazon — is underperforming the broader equity market in the second half of 2018.
Viking Therapeutics Won't Live Up To The Hype https://seekingalpha.com/article/4222613-viking-therapeutics-live-hype?source=feed_all_articles Nov 26, 2018 - VK-2809 has neither clinical data nor an IND in NASH and its development lags 2.5 - 3 years behind MGL-3196.Even if successful in a NASH trial, VK-2809 will be competing in a crowded space with variou
UBS Global Wealth Management to include environmental scores on its funds in 2019 https://www.cnbc.com/2018/12/03/ubs-global-wealth-management-to-includeenvironmental-scores-on-funds.html Dec 03, 2018 - UBS Global Wealth Management says the new assessments of equity and bond funds will include pollution, ethics and climate change.
THW: Global Healthcare Fund With 10%+ Yield https://seekingalpha.com/article/4226785-thw-global-healthcare-fund-10-percent-yield?source=feed_tag_etf_portfolio_strategy Dec 06, 2018 - THW is a Tekla healthcare fund much like THQ, but with an emphasis on holding global securities.THW currently has a quite attractive 10.55% yield.This fund is also showing a discount of 8.29%, but tha
Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals http://www.zacks.com/stock/news/342745/bausch-bhc-bids-for-assets-of-synergy-pharmaceuticals?cid=CS-ZC-FT-342745 Dec 13, 2018 - Bausch (BHC) bids to acquire certain assets of Synergy Pharma for $200 million.
End Of The Line For Synergy Pharmaceuticals https://seekingalpha.com/article/4229299-end-line-synergy-pharmaceuticals?source=feed_sector_healthcare Dec 19, 2018 - Synergy filed for bankruptcy after failing to amend the liquidity and revenue covenants of its loan facility with private lender CRG.Bausch Health has offered $200 million for its assets; other bids m
Why Allergan (AGN) Could Beat Earnings Estimates Again http://www.zacks.com/stock/news/345813/why-allergan-agn-could-beat-earnings-estimates-again?cid=CS-ZC-FT-345813 Jan 04, 2019 - Allergan (AGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merck Doesn't Want To Be Left Out Of The NASH Race Either, Uses Option Agreement https://seekingalpha.com/article/4231541-merck-want-left-nash-race-either-uses-option-agreement?source=feed_sector_healthcare Jan 04, 2019 - Merck takes option to license NGM313 drug for NASH, which will be used in a phase 2 study known under a different name as MRK-3655.The main deal between Merck & NGM Bio was $450 million to develop bio
Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet http://www.zacks.com/stock/news/347005/pharma-stock-roundup-lilly-to-buy-loxo-for-%248b-ma-in-focus-at-jp-morgan-meet?cid=CS-ZC-FT-347005 Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.

Pages: 1234

Page 1>

Related Companies

Name Exchange Price Mkt Cap
CELG Celgene Corporation NASDAQ $87.23 $61.35B
SHPG Shire plc NASDAQ $176.25 $46.08B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $175.8 $44.93B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.
AGN - Google Finance https://www.google.com/finance?q=AGN Industry related info and international coverage Summary News
AGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options